Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis

Bioscience, Biotechnology and Biochemistry

Volumn 78, Issue 10, 2014, Pages 1662-1668

  Iizuka, Mana ^a   Wakasa, Yuhya ^b   Tsuboi, Hiroto ^a   Asashima, Hiromitsu ^a   Hirota, Tomoya ^a   Kondo, Yuya ^a   Matsumoto, Isao ^a   Sumida, Takayuki ^a   Takaiwa, Fumio ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

Altered peptide ligands; Autoreactive T cells; Rheumatoid arthritis; Transgenic rice; Type ii collagen

Indexed keywords

ANTIGENS; COLLAGEN; EPITOPES; IMMUNIZATION; LIGANDS; MAMMALS; PEPTIDES; T-CELLS;

COLLAGEN-INDUCED ARTHRITIS; IMMUNE SUPPRESSION; ORAL ADMINISTRATION; PEPTIDE LIGAND; RHEUMATOID ARTHRITIS; TRANSGENIC RICE; TRANSGENIC RICE SEEDS; TYPE II COLLAGENS;

DISEASES;

MUS;

COLLAGEN TYPE 2; LIGAND; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTHRITIS, EXPERIMENTAL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; ORAL DRUG ADMINISTRATION; PLANT SEED; REGULATORY T LYMPHOCYTE; RICE; TRANSGENIC PLANT;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, EXPERIMENTAL; COLLAGEN TYPE II; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; ORYZA SATIVA; PEPTIDES; PLANTS, GENETICALLY MODIFIED; SEEDS; T-LYMPHOCYTES, REGULATORY;

EID: 84930698838     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2014.936349     Document Type: Article

References (23)

1. Struyk L, Hawes GE, Dolhain RJ, van Scherpenzeel A, Godthelp B, Breedveld FC, van den Elsen PJ. Evidence for selective in vivo expansion of synovial tissue-infiltrating CD4+CD45RO+ T-lymphocytes on the basis of CDR3 diversity. Ann. N.Y. Acad. Sci. 1995;756:204-207.
2. Taneja V, Behrens M, Basal E, Sparks J, Griffiths MM, Luthra H, David CS. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J. Immunol. 2008;181:2869-2877.
3. De Rosa MC, Giardina B, Bianchi C. Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. PLoS One. 2010;5:e11550.
4. Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, Maini RN, Feldmann M. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Nat. Acad. Sci. USA. 1989;86:636-640.
5. Sekine T, Kato T, Masuko-Hongo K, Nakamura H, Yoshino S, Nishioka K, Yamamoto K. Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis. Ann. Rheum. Dis. 1999;58:446-450.
6. Sloan-Lancaster J., Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 1996;14:1-27.
7. Chen YZ, Matsushita S, Nishimura Y. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation. J. Immunol. 1996;157:3783-3790.
8. Ohnishi Y, Tsutsumi A, Matsumoto I, Goto D, Ito S, Kuwana M, Uemura Y, Nishimura Y. Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients. Mod. Rheumatol. 2006;16:226-228.
9. Wakamatsu E, Matsumoto I, Yoshiga Y, Hayashi T, Goto D, Ito S, Sumida T. Altered peptide ligands regulate type II collagen-induced arthritis in mice. Mod. Rheumatol. 2009;19:366-371.
10. + T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res. Ther. 2003;6:R213-219.
11. Min SY, Park KS, Cho ML, Kang JW, Cho YG, Hwang SY, Park MJ, Yoon CH, Min JK, Lee SH, Park SH, Kim HY. Antigen-induced, tolerogenic CD11c+, CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. Arthritis Rheum. 2006;54:887-898.
12. Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat. Rev. Immunol. 2007;7:665-677.
13. Tiwari S, Verma PC, Singh PK, Tuli R. Plants as bioreactors for the production of vaccine antigens. Biotechnol. Adv. 2009;27:449-467.
14. Yusibov V, Rabindran S. Recent progress in the development of plant derived vaccines. Expert Rev. Vaccines. 2008;7:1173-1183.
15. Takaiwa F, Takagi H, Hirose S, Wakasa Y. Endosperm tissue is good production platform for artificial recombinant proteins in transgenic rice. Plant Biotechnol. J. 2007;5:84-92.
16. Takaiwa F. Update on the use of transgenic rice seeds in oral immunotherapy. Immunotherapy. 2013;5:301-312.
17. Qu L, Takaiwa F. Evaluation of tissue specificity and expression strength of rice seed component gene promoters in transgenic rice. Plant Biotechnol. J. 2004;2:113-125.
18. Wakasa Y, Yasuda H, Takaiwa F. High accumulation of bioactive peptide in transgenic rice seeds by expression of introduced multiple genes. Plant Biotechnol. J. 2006;4:499-510.
19. Wakasa Y, Ozawa K, Takaiwa F. Agrobacterium-mediated transformation of a low glutelin mutant of 'Koshihikari' rice variety using the mutated-acetolactate synthase gene derived from rice genome as a selectable marker. Plant Cell Rep. 2007;26:1567-1573.
20. Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Takaiwa F, Sumida T. Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen. Plant Biotechnol. J. (in press) doi: 10.1111/pbi.12223
21. + regulatory T cells. J. Immunol. 2004;172:5986-5993.
22. Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, Guo B, Herbert DR, Bulfone A, Trentini F, Di Serio C, Bacchetta R, Andreani M, Brockmann L, Gregori S, Flavell RA, Roncarolo MG. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 2013;19:739-746.
23. Okamura T, Fujio K, Sumitomo S, Yamamoto K. Roles of LAG3 and EGR2 in regulatory T cells. Ann. Rheum. Dis. 2012;71:96-100.